- 讲师介绍
- 视频介绍
讲师介绍
Dr. Robert Carnahan
Associate Professor of Pediatrics and Radiology, Vanderbilt University School of Medicine
Dr. Pavlo Gilchuk
Senior Staff Scientist, Vanderbilt Vaccine Center
点击查看更多讲师
视频介绍
Viral infectious diseases are emerging and re-emerging globally, which underscores the urgent need for accelerated discovery of antiviral therapeutics. Human antiviral monoclonal antibodies (mAbs) are promising drug candidates for clinical evaluation. High cost and long timelines required to develop therapeutic mAbs remain two of the key challenges.
This webinar will provide insights for researchers to learn how scientists have implemented accelerated discovery and validation of potent therapeutic mAbs using an integrated pipeline technology combining flow cytometry, bioinformatics, synthetic biology, and high-throughput analysis.
• Gain insight into flow cytometry, bioinformatics, and synthetic biology techniques used for mAb discovery and validation
• Understand the workflow for accelerating mAb therapeutics for use as antiviral agents
This webinar will provide insights for researchers to learn how scientists have implemented accelerated discovery and validation of potent therapeutic mAbs using an integrated pipeline technology combining flow cytometry, bioinformatics, synthetic biology, and high-throughput analysis.
• Gain insight into flow cytometry, bioinformatics, and synthetic biology techniques used for mAb discovery and validation
• Understand the workflow for accelerating mAb therapeutics for use as antiviral agents
